Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Vomiting 3Nausea 3Lymphoma 2Breast Neoplasms 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Sarcoma, Alveolar Soft Part 1Papillomavirus Infections 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Inflammatory Breast Neoplasms 1Gynecologic Cancer 1Colonic Neoplasms 1Carcinoma in Situ 1Burkitt Lymphoma 1Breast Neoplasms, Male 1

Interventions

Dexamethasone 51Aprepitant 39Palonosetron 37Ondansetron 31Granisetron 22Calcium Dobesilate 14fosaprepitant 13Olanzapine 13Therapeutics 8dexamethasone acetate 7ramosetron 6netupitant, palosentron drug combination 6casopitant 6Tropisetron 6Cyclophosphamide 6dexamethasone 21-phosphate 5Radiotherapy 5Metoclopramide 5Doxorubicin 5netupitant 4dolasetron 4Surveys and Questionnaires 4Dronabinol 4Acupressure 4Yoga 3Vincristine 3Tablets 3Psychiatric Rehabilitation 3Prochlorperazine 3Lorazepam 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Vomiting × Prochlorperazine × Clear all
NCT01843868 2024-08-07

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Australasian Leukaemia and Lymphoma Group

Phase NA Withdrawn
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Nausea, Vomiting

NCT00475085 2015-11-10

Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial

University of Rochester

Phase 3 Completed
1,021 enrolled 10 charts
Breast

Breast Neoplasms, Nausea, Vomiting, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT00020657 2015-10-15

Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer

University of Rochester

Phase 3 Completed

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡